Showing 541 - 560 results of 13,976 for search 'documents 12', query time: 0.12s Refine Results
  1. 541
  2. 542
  3. 543
  4. 544
  5. 545

    Impact of non‐binding FDA guidances on primary endpoint selection in Alzheimer's disease trials by Jeffrey C. Yu, Jakub P. Hlávka, Elizabeth Joe, Frances J. Richmond, Darius N. Lakdawalla

    Published 2022-01-01
    “…Results Among AD DMT trials, annual use of cognitive/functional composite endpoints significantly increased after the 2013 guidance (+12.9%, P < .001), and significantly decreased after the 2018 guidance (–19.9%, P = .022). …”
    Get full text
    Article
  6. 546
  7. 547
  8. 548
  9. 549
  10. 550
  11. 551
  12. 552
  13. 553
  14. 554
  15. 555
  16. 556
  17. 557
  18. 558
  19. 559
  20. 560